X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (461) 461
Publication (43) 43
Book Chapter (8) 8
Book / eBook (3) 3
Conference Proceeding (3) 3
Book Review (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (212) 212
female (122) 122
male (118) 118
middle aged (118) 118
index medicus (112) 112
oncology (112) 112
adult (104) 104
hematology (93) 93
aged (90) 90
chemotherapy (71) 71
antineoplastic combined chemotherapy protocols - therapeutic use (65) 65
non-hodgkins-lymphoma (62) 62
treatment outcome (62) 62
rituximab (61) 61
prognosis (50) 50
cancer (49) 49
lymphomas (46) 46
adolescent (45) 45
survival analysis (41) 41
aged, 80 and over (40) 40
transplantation (39) 39
antineoplastic combined chemotherapy protocols - administration & dosage (34) 34
combined modality therapy (34) 34
survival (34) 34
therapy (33) 33
cyclophosphamide - administration & dosage (32) 32
recurrence (32) 32
disease-free survival (31) 31
transplantation, autologous (31) 31
lymphoma (30) 30
doxorubicin - administration & dosage (29) 29
elderly-patients (29) 29
lymphoma, large b-cell, diffuse - drug therapy (29) 29
neoplasm staging (27) 27
trial (27) 27
antineoplastic combined chemotherapy protocols - adverse effects (26) 26
survival rate (25) 25
antibodies, monoclonal, murine-derived (24) 24
care and treatment (24) 24
lymphoma, non-hodgkin - drug therapy (24) 24
young adult (24) 24
b-cell lymphoma (23) 23
hemic and lymphatic diseases (23) 23
high-dose chemotherapy (23) 23
prednisone - administration & dosage (23) 23
prospective studies (23) 23
cyclophosphamide (22) 22
retrospective studies (22) 22
risk factors (22) 22
vincristine - administration & dosage (22) 22
stem cells (21) 21
antibodies, monoclonal - administration & dosage (20) 20
antineoplastic agents - therapeutic use (20) 20
immunology (20) 20
remission induction (20) 20
animals (19) 19
antineoplastic agents - administration & dosage (19) 19
bone-marrow-transplantation (19) 19
hematology, oncology and palliative medicine (19) 19
life sciences (19) 19
non-hodgkin's lymphomas (19) 19
analysis (18) 18
research (18) 18
antibodies, monoclonal - therapeutic use (17) 17
hematopoietic stem cell transplantation (17) 17
high-dose therapy (17) 17
lymphoma, large b-cell, diffuse - pathology (17) 17
lymphoma, large b-cell, diffuse - therapy (17) 17
stem cell transplantation (17) 17
stem-cell transplantation (17) 17
disease (16) 16
classification (15) 15
doxorubicin (15) 15
follow-up studies (15) 15
health aspects (15) 15
leukemia (15) 15
lymphoma, large b-cell, diffuse - mortality (15) 15
lymphoma, non-hodgkin - therapy (15) 15
aggressive lymphoma (14) 14
european medicines agency (14) 14
hodgkin disease - drug therapy (14) 14
salvage therapy (14) 14
antibodies, monoclonal, murine-derived - therapeutic use (13) 13
bone-marrow transplantation (13) 13
drug therapy (13) 13
medicine, general & internal (13) 13
patients (13) 13
regimen (13) 13
chemistry, multidisciplinary (12) 12
chop chemotherapy (12) 12
cyclophosphamide - therapeutic use (12) 12
cytarabine - administration & dosage (12) 12
lymphoma - drug therapy (12) 12
medicine (12) 12
mice (12) 12
non-hodgkin's lymphoma (12) 12
prednisone (12) 12
time factors (12) 12
antibodies, monoclonal, murine-derived - administration & dosage (11) 11
chemotherapy plus rituximab (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 11/2018, Volume 36, Issue 32, pp. 3272 - 3273
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 9, pp. 1183 - 1184
Journal Article
Journal Article
Journal Article
The Lancet Haematology, ISSN 2352-3026, 10/2018, Volume 5, Issue 10, pp. e435 - e436
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2010, Volume 28, Issue 27, pp. 4184 - 4190
Purpose Salvage chemotherapy followed by high-dose therapy and autologous stem-cell transplantation (ASCT) is the standard treatment for relapsed diffuse large... 
SURVIVAL | PARMA TRIAL | THERAPY | BONE-MARROW TRANSPLANTATION | ONCOLOGY | NON-HODGKINS-LYMPHOMA | CHOP | AGGRESSIVE LYMPHOMA | RANDOMIZED CONTROLLED-TRIAL | CHEMOTHERAPY PLUS RITUXIMAB | ELDERLY-PATIENTS | Recurrence | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | New York City | Stem Cell Transplantation | Young Adult | Time Factors | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Antigens, CD20 - analysis | Chemotherapy, Adjuvant | Antibodies, Monoclonal, Murine-Derived | Dexamethasone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - surgery | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Europe | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Rituximab | Etoposide - administration & dosage | Treatment Outcome | Cytarabine - administration & dosage | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Ifosfamide - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Israel | Australia | Neoplasm Staging | Bone2 | Original Reports | Hema13 | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | Surgery | Onkologi | Oncology | Cancer and Oncology | Klinisk medicin | MEDICINE | Kirurgi | Cancer och onkologi
Journal Article
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 09/2018, p. JCO1800498
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2009, Volume 27, Issue 23, pp. 3822 - 3829
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 9, pp. 1182 - 1189
Purpose Peripheral T-cell lymphoma (PTCL) is a poor prognosis subtype of non-Hodgkin's lymphoma with no accepted standard of care. This study evaluated the... 
WORKSHOP